The 2026 revision of the Implementing Regulation of the Drug Administration Law, effective May 15, 2026, was recently passed by China’s State Council.
China’s 2025 revision to the Anti-Unfair Competition Law (AUCL), effective 15 October 2025, marks a major regulatory shift aimed at strengthening market integrity and aligning with global enforcement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results